00/410

MAPREC assay of poliovirus type 1 (Sabin).* 480-A, 525-C DNA(1st International Reference Preparation)

00/416

Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/418

MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)

00/422

High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)

00/440

Influenza Antiserum A/Singapore/1/57 (H2)

00/442

Influenza anti B/Yamanashi/166/98 Serum (sheep)

00/464

Streptokinase (3rd International Standard 2001)

00/500

Botulinum Type A-E Antitoxin, Human Serum

00/530

Influenza Virus infectious B/Sichuan/379/99

00/542

Influenza anti- A/Chick/Scotland/59 (H5N1) Serum

00/544

Influenza Virus infectious B/Victoria/504/00

00/546

Influenza Antigen B/Johannesburg/5/99

00/552

Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)

00/556

Influenza anti-B/Johannesburg/5/99/ Serum

00/562

Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)

00/572

Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)

00/574

Interferon Beta SER17 Mutein (Human, rDNA derived)

00/576

Interferon Beta (Human, Fibroblast-derived, Glycosylated)

00/614

Influenza virus infectious B/Guangdong/120/2000

007SP

Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)

01/412

Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody

01/420

Interleukin-17 (Human rDNA derived)(International Reference Reagent)

01/424

Vascular Endothelial Growth Factor, Human rDNA derived

01/426

Meningococcal group Y polysaccharide

01/428

Meningococcal serogroup W polysaccharide

01/450

Influenza anti B/Guangdong/120/2000 Serum

01/452

Influenza anti A/Panama/2007/99 (H3N2) HA serum

01/506

Botulinum type F antitoxin, equine

01/508

Botulinum type C antitoxin, equine

01/510

Botulinum Antitoxin Equine Type D

01/512

Botulinum type G antitoxin, equine

01/514

Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody

01/528

Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)

01/530

Oral Poliovaccine Sabin Type 2 reference strain (Panel of 5 ampoules)

01/532

Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)

01/538

Anti-Meningococcal Serosubtype P1.16 mAb

01/546

Influenza Antigen B/Guangdong/120/2000

01/572

Anti-D Immunoglobulin(2nd International Standard)

01/580

Thrombin, human(2nd International Standard)

01/600

Anti-Toxoplasma IgG, Human(International Standard)

01/602

Anti-Parvovirus B19, plasma, human(2nd International Standard)

01/612

Influenza Virus infectious B/Hawaii/10/01

01/614

Influenza Antigen A/New Caledonia/20/99

02/102

Influenza anti A/Panama/2007/99 Serum

02/144

Anti-Meningococcal Serosubtype P1.15 mAb

02/148

Anti-Meningococcal Serosubtype P1.4 mAb

02/168

Prekallikrein Activator (PKA), Human(2nd International Standard)

02/178

Anti-Meningococcal Serosubtype P1.2 mAb

02/180

Anti-Meningococcal Serotype P2.2a mAb

02/182

Anti-Japanese Encephalitis Virus Plasma, Human

02/184

Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human

02/206

Factor XIII Plasma, Human (1st International Standard)

02/210

HIV (antibody), 1st International Reference Panel

02/226

IVIG negative control for use with IVIG + anti-D(International Reference Reagent)

02/228

IVIG + anti-D for use with negative control IVIG(International Reference Reagent)

02/230

Biotinylated Brad-5 (Bio-Brad-5)

02/232

Tetanus Toxoid (Non-Adsorbed)

02/254

Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)

02/262

Influenza Virus infectious B/Brisbane/32/2002

02/264-005

HCV RNA Working Reagent for Nucleic Acid Amplification Techniques

02/286

Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)

02/294

Influenza Antiserum A/chick/Italy/1347/99 (H7N1)

02/306

Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)

02/308

Anti-Meningococcal Serotype P3.4 mAb

02/310

Anti-Meningococcal Serotype P3.15 mAb

02/318

Botulinum Antitoxin Equine Type E

02/320

Anti-Meningococcal Serosubtype P1.3 mAb

02/336

Influenza Antigen A/New Caledonia/20/99

02/338

Influenza anti A/Panama/2007/99 Serum

02/342

Protein C Plasma, Human(2nd International Standard)

03/104-016

HTLV-1 (antibody) Monitor Sample

03/110

Influenza anti B/Shangdong/9/97 Serum

03/114

Anti-Meningococcal Serosubtype P1.1 mAb

03/116

Blood Coagulation Factor V, Plasma Human (1st International Standard)

03/124

Thrombopoietin ( Human rDNA derived)

03/142

Anti-Meningococcal Serosubtype P1.14 mAb

03/148

Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)

03/150

Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)

03/152

Anti-HPA-1a (International Standard)

03/164

Anti-B minimum potency reference preparation(International Standard)

03/178

Vitamin B12, Serum Folate and holoTC (International standard)

03/182

Anti-Meningococcal Serotype P3.21 mAb

03/188

Anti-A minimum potency reference preparation(International Standard)

03/190

Anti-HPA-3a(minimum potency)(International Reference Reagent)

03/192

Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)

03/198

Influenza Virus infectious A/Kumamoto/102/02

03/200

Interleukin - 18 (Human rDNA derived)(International Reference Reagent)

03/210

Anti-Meningiococcal Serosubtype P1.6 mAb

03/212

Influenza anti A/Wyoming/03/03 Serum

03/220

Influenza Antigen A/Wyoming/03/03

03/224

Anti-Meningococcal Serosubtype P1.10 mAb

03/226

Anti-Meningococcal Serosubtype P1.5 mAb

03/228

Protein S, Plasma, Human(2nd International Standard)

03/236

Anti-Meningococcal Serosubtype P1.13 mAb

03/242

Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum

03/244

Influenza Antiserum A/chick/Germany/N/49

03/258

Influenza Antigen A/New Caledonia/20/99 (IVR-116)

03/262

Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)

04/102

Blood Coagulation Factor XI Plasma, Human(1st International Standard)

04/122

Anti-Meningococcal Serosubtype P1.12 mAb

04/132

IVIG + Anti-D for use with negative control IVIG

04/140

IVIG Negative Control for use with IVIG & Anti-D

04/150

Tetanus Toxoid For Flocculation Test(2nd International Standard)

04/160

Influenza Virus infectious NYMC X-147

04/166

TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)

04/170

Influenza Virus infectious A/Wellington/1/2004

04/172

Influenza Virus infectious IVR-139

04/176

Plasmodium falciparum DNA for NAT Assays(1st International Standard)

04/198

Anti-Meningococcal Serotype P3.1 mAb

04/200

Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)

04/202

Influenza Antigen B/ Jiangsu/10/2003

04/214

Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)

04/224

Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004

04/228

Influenza anti B/ Neuraminidase Serum

04/230

Influenza anti N1 Neuraminidase Serum

04/242

Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)

04/246

Anti-Meningococcal Serogroup W-135 mAb

04/248

Anti-Meningococcal Serosubtype P1.19 mAb

04/252

Protein C Concentrate, Human(1st International Standard)

04/258

Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)

04/260

Influenza anti A/New Caledonia/20/99 HA Serum (sheep)

04/262

Influenza anti A/New York/55/2004 HA Serum (sheep)

04/264

Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)

05/102

Influenza Virus infectious NYMC BX-7

05/106

Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)

05/110

Influenza Virus infectious A/California/7/2004

05/112

Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).

05/122

Syphilitic plasma IgG (human)(1st International Standard)

05/130

Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)

05/132

Syphilitic plasma IgG and IgM (human)(1st International Standard)

05/134

Anti-human papillomavirus type 16 serum (1st International Standard)

05/138

Influenza Virus infectious B/Shanghai/361/2002

05/162

Alpha-1-Antitrypsin, plasma derived(1st International standard)

05/190

Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody

05/192

Anti Meningococcal Serotype P2.2b Monoclonal Antibody

05/234

Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)

05/236

Influenza anti A/Wisconsin/67/2005 Serum (sheep)

05/242

IVIG, Anti-D and Negative Control Panel

05/252

Influenza anti B Neuraminidase Serum (Sheep SH463)

06/108

Influenza Virus infectious IVR-116

06/114

Influenza Virus Infectious A/PR/8/34

06/124

Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 (1st International Standard)

06/128

Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 (1st International Standard)

06/140

Pertussis Antiserum(human)1st IS-WHO international Standard.

06/142

Pertussis Antiserum (Human) 1st WHO Reference Reagent

06/164

Influenza Virus infectious 1 VR-142

06/166

Antithrombin Concentrate, Human (3rd International Standard)

06/170

Influenza Antigen A/New Caledonia/20/99

06/192

Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)

06/202

Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)

06/206

Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)

06/242

Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)

07/102

Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)

07/104

Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)

07/112

Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23

07/132

Influenza Virus infectious B/Malaysia/2506/2004

07/144

Influenza Virus infectious IVR-145,

07/146

Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)

07/148

Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum

07/150

Human Plasma Anti-Influenza H5N1 (1st International Standard)

07/164

Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)

07/182

Blood Coagulation Factor IX Concentrate, Human (4th International Standard)

07/184

Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)

07/202

Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)

07/214

Positive Control for use in flow cytometry cross matching (FCXM)

07/216

Diphtheria Toxoid (Adsorbed) (4th International Standard)

07/222

RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)

07/226

Influenza Virus Infectious A/New Caledonia/20/99

07/228

Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”

07/246

Influenza Virus Infectious IVR-147

07/268

Influenza Virus Infectious B/Brisbane/3/2007

07/270

BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)

07/272

BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)

07/274

BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)

07/278

Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)

07/286-012

Hepatitis B Surface Antigen Monitor Sample

07/288-012

Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml

07/290

Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6

07/294-005

Norovirus GII for Nucleic Acid Amplification Techniques

07/296-005

Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques

07/298-004

Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques

07/300-004

Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques

07/304

Anti-D for assuring operator and test performance

07/306

Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)

07/316

Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)

07/318

Meningococcal Group C Polysaccharide

07/326

Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.

07/328

Unfractionated Heparin (6th I.S.)

07/336

Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60

07/338

Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)

07/348

Influenza Virus infectious NYMC X-171B

07/350

Blood Coagulation Factor VIII Concentrate (8th I.S.)

07/358

Influenza Virus infectious NIB-50

07/362

Influenza Virus infectious IVR-149

07/364

Chorionic Gonadotrophin, (5th International Standard)

07/B498-16

QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1

08/100

Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)

08/108

Influenza Virus Infectious NIBRG-91

08/114-005

Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques

08/118-004

Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques

08/120-005

Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques

08/126

Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)

08/138

Influenza Virus Infectious B/Florida/4/2006

08/140

Influenza Antigen B/Florida/4/2006

08/142

Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)

08/148

Positive control for Luminex based anti-HLA Class II serology

08/150

HIV-2 RNA(1st International Standard)

08/154

Influenza Virus Infectious NIBRG-12

08/156

Influenza Virus Infectious NIBRG-23 30060 VE3

08/158

Fragile X Syndrome gDNA (1st International Genetic Reference Panel)

08/160

Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)

08/174-006

Human Coxsackie B4 for Nucleic Acid Amplification Techniques

08/176-004

Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques

08/178-004

Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques

08/180-004

Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques

08/184

Influenza Antigen B/Malaysia/2506/2004

08/202

Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)

08/204

Thyroid Stimulating Antibody (2nd I.S.)

08/208

Influenza Antigen Hong Kong/1073/99 (H9N2)

08/210

Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)

08/214

Meningococcal Serogroup C polysaccharide (1st International Standard)

08/216

Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)

08/218

Tetanus Toxoid Adsorbed (4th International Standard)

08/224-005

Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques

08/226-005

Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques

08/228

Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91

08/230

Streptodornase (2nd International Standard)

08/246

Influenza anti A/Brisbane/10/2007- like HA serum

08/256

C1- Inhibitor, Concentrate (1st International Standard)

08/258

Antithrombin, Plasma (3rd International Standard)

08/262

C1 Inhibitor (Plasma)(1st International Standard)

08/266

Sex Hormone Binding Globulin.(2nd International Standard)

08/268

Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107

08/278

Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))

08/282

Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)

08/298

Influenza Virus Infectious B/Brisbane/33/2008 30720 E5

08/300

Influenza Virus Infectious IVR-148

08/304

Influenza virus infectious NYMC X-175C

08/310-005

Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)

08/314-006

Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)

08/316-005

Epstein-Barr Virus for Nucleic Acid Amplification Techniques

08/318-005

Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing

08/320-007

Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing

08/322-004

Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing

08/356

Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)

08/362

Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109

09/100

Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)

09/110

Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)

09/112

Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology

09/130

Influenza Virus Infectious NIBRG-122

09/136

Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)

09/138

Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)

09/140

Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)

09/148

Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)

09/154

Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)

09/162

Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)

09/170

Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody

09/172

Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)

09/174

Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)

09/182

VWF Factor Concentrate (2nd International Standard)

09/184

Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14

09/186

Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)

09/188

Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)

09/196

Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)

09/222

Human anti-Haemophilus influenzae b reference serum

09/234

Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)

09/236

Influenza Virus Infectious IVR-153

09/242

Fibrinogen Concentrate (B)(2nd International Standard)

09/260

Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)

09/264

Fibrinogen Plasma (D)(3rd International Standard)

09/266

GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived

09/268

Influenza Virus Infectious NIBRG-121xp

09/272

Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)

09/274

Influenza Virus Infectious NYMC X-185

09/280

Influenza Virus Infectious NIB-64

09/284

Anti-Human Neutrophil Antibody 1a WHO Reference Reagent

09/296

Pro-Insulin, human (1st International Standard)

09/304

Influenza Virus Infectious IVR-155

09/306

Influenza Virus Infectious NIBRG-147

09/308

Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)

09/310

Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)

09/316

Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)

09/B558-06

QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices

09/B584-12

QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

09/B588-07

QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1

10/104

Reteplase Reference Material

10/120

Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum (sheep 516 and 517)

10/128

Diphtheria Polyclonal Antibody

10/130

Diphtheria Monoclonal Antibody

10/132

Tetanus Polyclonal Antibody

10/134

Tetanus Monoclonal Antibody

10/136-001

HLA-DRB1 Genotyping Reference Panel

10/140

Anti-human papillomavirus[HPV] 18 serum (1st International Standard)

10/142

Negative control for Luminex based anti-HLA serology

10/152

HIV-1 RNA (3rd International standard)

10/154-005

Anti-HCV (1 in 8 dilution)(British Working Standard)

10/176

Interleukin-29 (Interferon Lamda 1)

10/178

Endotoxin (3rd International Standard)

10/188

Factor VIII Concentrate (13th British Standard).

10/198

Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)

10/202

Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)

10/214

Influenza Anti N2 Neuraminidase Serum SH395 & SH396

10/218

Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)

10/226

Influenza Virus Infectious IVR-158

10/232

Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)

10/234

Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)

10/236

Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)

10/238

Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)

10/242

Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)

10/252

Factor VII Concentrate(2nd International Standard)

10/258

Influenza Antigen A/California/7/2009-like(NIB-74)

10/260

Influenza Virus Infectious NIB-58

10/262

Diphtheria Antitoxin Human IgG(1st International Standard)

10/264

Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)

10/272

BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)

10/276

Influenza virus infectious BX-31

10/276

Influenza virus infectious BX-31

10/280

Anti-HLA Control

10/286

Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)

10/B592-09

QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1

10/B594-06

QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1

10/B596-09

QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1

1050

* ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)

11/106

Influenza Virus infectious A/Perth/16/2009

11/106

Influenza Virus infectious A/Perth/16/2009

11/108

Influenza Virus infectious NYMC X-187

11/108

Influenza Virus infectious NYMC X-187

11/126

Factors II and X Concentrate (4th International standard)

11/130

Influenza Virus Infectious NIBRG-14

11/130

Influenza Virus Infectious NIBRG-14

11/134

Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)

11/170

Erythropoietin, recombinant, for Bioassay (3rd International Standard)

11/176

Low Molecular Weight Heparin 2 (3rd International Standard)

11/182-001

HBV DNA Working Reagent

11/184

High Molecular Weight Urokinase(2nd International Standard)

11/206

Influenza anti-A/Perth/16/2009 HA Serum

11/208-001

Parvovirus B19 DNA

11/210

Anti-human CD4 FITC conjugated 0.5ml

11/214

Blood Group Genotyping Reference Panel ((International Reference Reagent)

11/216

Chagas Antibody Reference Panel ( 1st International Standard)

11/218-001

MLH1/MSH2 Exon Copy Number Reference Panel

11/222

Influenza Virus Infectious NIB-79

11/226

Influenza Virus Infectious A/Victoria/361/2011

11/232

Influenza Virus Infectious B/Texas/6/2011

11/234

Immunoglobulin E(IgE) human serum (3rd International Standard)

11/244

Influenza Virus Infectiious NYMC BX-49

11/B601-05

QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1

11/B603-06

QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2

11/B604-002

QCRFLUAH5QC1 Influenza H5 PC1

11/B606-05

QCRNEGQC1-Negative Quality Control Serum: Sample1

11/B608-02

QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1

12/100

Influenza Virus Infectious NYMC X-217

12/104

International Standard for * 12/104 (3rd International Standard)

12/106

Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)

12/110

Influenza Antigen B/Wisconsin/1/2010 (cell derived)

12/112

Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)

12/114

Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)

12/116

Influenza anti-A/Victoria/361/2011-like HA serum

12/118

Influenza anti-B/Wisconsin/1/2010-like HA serum

12/122

Influenza virus infectious A/turkey/Italy/3889/1999

12/154

Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)

12/168

Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived

12/172

3rd HCV RNA Genotype Panel for Nucleic acid amplification techniques

12/174

Infectious Virus Influenza A/California/7/2009

12/176

Methylated Human Serum Albumin (mHSA)

12/188

Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard)

12/196-001

Hereditary Haemochromatosis Genotyping Reference Panel

12/198

Influenza virus infectious B/Wisconsin/1/2010 34490 E5

12/200

Influenza virus infectious B/Brisbane/60/2008 34500 E7

12/202

Influenza virus infectious NYMC BX-39

12/204

Influenza Virus infectious IVR-165

12/208

Parvovirus B19 (3rd International Standard)

12/224

HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)

12/226

HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

12/248-001

JAK2 V617F Genotyping Sensitivity Panel

12/252

ADAMTS 13 Plasma (1st International Standard)

12/282

Diphtheria Toxin 1Lf/ml

12/284

Anti-meningococcal serogroup Y monoclonal antibody

12/290

Influenza Virus Infectious B/Brisbane/36/2012

12/294

Influenza Virus Infectious NYMC BX-51C

12/298

Influenza Virus Infectious A/Texas/50/2012

12/306

Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)

12/B611-02

Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1

12/B612-04

QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1

12/B613-03

QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2

12/B614-05

QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1

12/B620-04

QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2

12/B622-06

QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1

12/B623-003

QCRFLUAH1N1QC1-Influenza AH1N1 QC1

13/100

Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)

13/102-001

Hepatitis A Virus RNA Working Reagent

13/106

Influenza Antigen B/Massachusetts/02/2012

13/108

Anti-Meningococcal serogroup B monoclonal antibody

13/112

Influenza Antigen A/Texas/50/2012 (NYMC X-223)

13/116

Influenza Antigen A/Texas/50/2012 (NYMC X-223A)

13/126

Influenza anti-B/Brisbane/60/2008-like HA serum

13/132

Anti-Toxoplasma IgM Human. (4th International Standard).

13/134

Influenza Antigen B/Massachusetts/02/2012 (Egg derived)

13/146

C-Peptide, Human. 1st International Standard.

13/152

Influenza Antigen B/Massachusetts/02/2012 (cell derived)

13/162

Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)

13/164

Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)

13/166

Influenza anti-A/Anhui/1/2013 (N9) NA Serum

13/168-001

Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques

13/172

Lupus Anticoagulant (1st International Reference Panel)

13/176

Influenza Virus Infectious NIBRG-88

13/178

Influenza Anti-A/Texas/50/2012-like HA Serum

13/180

Influenza A/Anhui/1/2013 (H7) HA Serum

13/182

Influenza Anti-B/Massachusetts/02/2012-like HA Serum

13/198

Influenza Virus Infectious NYMC X-181

13/200

Influenza Virus Infectious NIB-74

13/202

Influenza Virus Infectious NIB-74xp

13/206

Plasmin (4th International Standard)

13/212

Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)

13/214

HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)

13/216

Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal

13/218

Polio Anti Sabin type 1 (inactivated) Serum

13/220

Polio Anti Sabin type 2 (inactivated) serum

13/222

Polio Anti Sabin type 3 (inactivated) serum

13/224

Influenza virus Infectious NIB-85. 36210 E5

13/228

Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4

13/234

Influenza antigen B/Brisbane/60/08

13/242

FEIBA Concentrate 2nd NIBSC Working Reference Standard

13/246

Meningococcal serogroup A polysaccharide. 1st WHO International Standard.

13/248

Influenza virus infectious NIBRG-267

13/250

Influenza Virus Infectious NIBRG-268

13/252

Influenza virus infectious NYMC X-223A

13/254

Influenza Anti-B/Brisbane/60/2008-HA serum

13/256

Influenza virus infectious. NYMC x-233

13/258

Influenza virus infectious NYMC X-233A

13/264

Influenza Virus Infectious NYMC X-223

13/B625-04

QCRHBsGQC2-HBsAg Quality Control Serum: Sample2

13/B627-03

QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1

13/B629-03

QCRHBeQC1-Anti-HBe Quality Control Serum: sample1

13/B631-03

QCRHBsGQC1-HBsAg Quality Control Serum: Sample1

13/B634-02

QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2

13/B636-03

QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2

13/B638-03

QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2

13/B640-01

QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5

13/B642-04

QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1

13/B644-01

QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3

13/B650-01

QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1

14/106

Influenza virus infectious. NYMC BX-51B

14/114

JC Virus (JCV) International Standard.

14/116

Influenza virus infectious NYMC X-179A

14/118

Influenza virus infectious B/Massachusetts/2/2012

14/144

Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) (sheep SH598)

14/146

Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)

14/148

Human Coagulation Factor IX Concentrate. 5th International Standard.

14/150

Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)

14/154

Influenza virus infectious. NYMC BX-35

14/156

Meningococcal group X polysaccharide. 1st WHO International Standard.

14/160

High titre anti-A in IVIG working reference reagent

14/198-001

HBV,HCV,HIV Multiplex

14/200

Influenza Antigen A/Puerto Rico/8/34 (HINI)

14/204

Influenza Virus Infectious B/Brisbane/9/2014

14/206

Influenza virus infectious NYMC X-247

14/212

BK Virus (BKV) International Standard

14/224

Influenza virus infectious. A/Switzerland/9715293/2013

14/226

Influenza Virus Infectious A/South Australia/55/2014

14/228

Influenza Virus Infectious A/Stockholm/6/2014

14/230

Influenza Virus Infectious. A/Norway/466/2014

14/232

Influenza Virus Infectious IVR-175

14/240-002

British Working Standard for Anti-HCV

14/248

Influenza Anti-B/Phuket/3073/2013 HA serum

14/250

Influenza Antigen. A/Anhui/1/2013 (H7N9) NIBRG-268

14/252

Influenza Antigen B/Phuket/3073/2013

14/254

Influenza Antigen A/Switzerland/9715293/2013 (NIB88)

14/266

Diphtheria Antitoxin Equine (DI) 1st International Standard

14/272

Influenza Anti-A/Switzerland/9715293/2013-like HA serum

14/274

Influenza Antigen B/Brisbane/9/2014 (Egg Derived)

14/290

4th HCV RNA Genotype Panel for Nucleic Acid Amplification

14/300

High titre anti-A and anti-B in serum. WHO Reference Reagent.

14/306

Influenza Virus Infectious NYMC X-243 40180 E13

14/308

Influenza Virus Infectious IVR-178 40200 E7

14/310

Influenza anti-A/California/7/09 HA serum

14/312

Influenza Virus Infectious B/Phuket/3073/2013

14/314

Influenza Virus Infectious NIB-88

14/320

Influenza Virus Infectious B/Utah/9/2014

14/322

Influenza Virus Infectious NIB-91

14/B651-01

QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2

14/B653-01

QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3

14/B654-01

QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1

14/B655-01

QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1

15/100

Influenza Antigen B/Utah/9/2014 (Cell Derived)

15/104

Influenza Antigen A/South Australia/55/2014 Cell derived

15/136

EBOV RNA NP-VP35-GP in-run control

15/138

EBOV RNA VP40-L in-run control

15/148

Influenza Virus Infectious NIB-92

15/154

Influenza Virus Infectious NIB-93

15/158

Influenza Virus Infectious NYMC X-263

15/184

Influenza Virus Infectious NYMC X-263B

15/188

Influenza Virus Infectious NYMC X-263A

15/192

Influenza Virus Infectious A/Hong Kong/4801/2014

15/194

Influenza Virus Infectious NYMC X-257A

15/196

Influenza Virus Infectious NYMC X-261

15/212

Influenza Virus Infectious NYMC BX-53C

15/220

Anti-EBOV plasma, human WHO Reference Reagent

15/222

EBOV RNA NP-VP35-GP WHO Reference Reagent

15/224

EBOV RNA VP40-L WHO Reference Reagent

15/230

Influenza Antigen A/Hong Kong/4801/2014 (NYMCX-263B) (Egg derived antigen)

15/234

Influenza Virus Infectious B/Texas/2/2013 41340 E7

15/236

Influenza Anti-A/Hong Kong/4801/2014 Like HA serum (sheep 640,641,642,643)

15/238

Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)

15/B658-01

QCRLYMEQC1 - Anti-Lyme QC1

15/B661-01

IgM Anti-Lyme QC1

15/B664-01

Anti-MumpsQC1

15/B667-01

QCRMEASQC1 Anti-MeaslesQC1

234

* ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)

2BADS

Anti-Brucella Abortus Serum, Bovine (International Standard)

2CPBETAAT

Clostridium Perfringens Beta Antitoxin (2nd International Standard)

2CPEPSILONAT

Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)

520

* ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)

59/015

Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine

59/016

Corticotrophin (ACTH), Porcine (3rd International Standard)

59/021

Botulinum Antitoxin Equine Type A

60/001

Botulinum Antitoxin Equine Type B

60/013

Tetanus Antitoxin, Equine, for Bioassay

61/001

Botulinum Antitoxin Equine Type D (1st International Standard)

62/001

Serum Gonadotrophin, Equine (2nd International Standard)

62/014

Lysine Vasopressin, Porcine

63/005

Gas Gangrene Antitoxin (Cl. Histolyticum), Equine

63/007

Diphtheria Antitoxin, Equine, for Flocculation Test

64/002

Rheumatoid Arthritis Serum

64/014

Gas Gangrene Antitoxin (Cl. Septicum), Equine

64/024

Gas Gangrene Antitoxin (Cl. Oedematiens), Equine

65/093

Anti-Thyroglobulin Serum, Human (International Reference reagent)

65/119

Renin, Porcine

65/122

Long-acting Thyroid Stimulator, Human

66/021

Tetanus Antitoxin, Equine, for Flocculation Test

66/138

Gastrin II, Porcine

66/153

Diphtheria Antitoxin, Equine

66/233

Anti-Nuclear Factor Serum (Homogenous) Human

66/387

Anti-thyroid Microsome Serum, Human

67/037

Immunoglobulin D (IgD) Serum, Human

67/086

Immunoglobulins G, A, M Serum Human (International Standard)

67/099

Immunoglobulins G, A & M Serum Human

67/182

Anti-Rubella Serum, Human

67/183

Primary Biliary Cirrhosis Serum, Human

68/340

Anti-Nucleolar Factor Plasma, Human

68/356

Renin, Human (International Standard)

69/017

Diphtheria Toxoid, Plain

69/065

Autoimmune Antibody to Human Spermatazoa

69/194

Glucagon, Porcine (First International Standard)

70/302

Angiotensin II (25µg)

71/328

Angiotensin I

73/515

Anti-D (Rho) Antibodies, Human

73/545

Placental Lactogen, Human (International Reference Preparation)

73/554

Cholera Vaccine (Inaba)

73/556

Cholera Vaccine (Ogawa)

73/601

Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)

74/520

Serum Proteins (Other than Immunoglobulins) Human

74/555

Corticotrophin (ACTH), Human

74/581

Ancrod (1st International Reference Preparation)

74/586

Corticotrophin (ACTH), Porcine

75/506

Cocksfoot Pollen Extract

75/533

Chorionic Gonadotrophin, Human, for Radioiodination

75/535

Chorionic Gonadotrophin beta, Human, for Radioiodination

75/551

Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)

75/569

Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)

75/595

Blood Coagulation Factor Xa, Bovine

76/508

Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination

76/515

Mannan (C. Albians) Purified

76/522

Opacity 5IRP

76/525

Anti-Birch Pollen Serum, Human

76/547

Influenza anti A/Victoria/3/75 Serum(goat)

76/575

Oxytocin(4th International Standard)

77/503

Anti-Cocksfoot Serum, Human

77/512

Lysine Vasopressin(1st International Standard)

77/530

Influenza Antigen A/New Jersey/8/76

77/531

Influenza anti A/New Jersey/8/76(H1N1) Serum(sheep)

77/568

Influenza anti B/Hong Kong/8/73 Serum(sheep)

77/584

Anti-D Pteronyssinus Serum, Human

77/600

Mannan (C. Albicans) Purified

77/616

Twelve Grass Pollen Extract

77/643

Secretin

77/662

Acarus Siro Extract

77/664

Glycyphagus destructor Extract

78/517

Tyrophagus Putrescentiae Extract

78/543

Kininogenase, Porcine

78/545

Anti-Aspergillus fumigatus Serum, Human

78/554

Luteinizing Hormone, Pituitary, alpha subunit (International Standard)

78/556

Luteinizing Hormone, Pituitary, beta subunit (International standard)

78/560

Influenza Antigen A/Texas/1/77

78/569

Influenza anti A/Texas/1/77 Serum (sheep)

78/575

Aspergillus Fumigatus Extract

78/582

Tyrophagus Longior Extract

78/628

Bee Venom

79/500

Parathyroid Hormone, Human (1st International Ref. Preparation)

79/516

Influenza anti A/Brazil/11/78 Serum (goat)

79/552

Influenza Antigen A/USSR/92/77

79/558

Influenza Antigen A/USSR/92/77

79/560

Influenza Antigen A/Brazil/11/78

79/568

Influenza Antigen B/Hong Kong/8/73

79/572

Prekallikrein Activator (PKA), Human

80/505

Growth Hormone, Human, Pituitary

80/517

Influenza Antigen A/Bangkok/1/79

80/519

Influenza Antigen B/Singapore/222/79

80/523

Influenza anti B/Singapore/222/79 Serum

80/525

Influenza anti A/Bangkok/1/79 Serum (sheep)

80/590

Tetracosactide

81/535

Luteinizing Hormone, Human, Pituitary (3rd International Standard)

81/565

Thyroid Stimulating Hormone, Human

82/508

Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment

82/512

Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment

82/518

Dermatophagoides Pteronyssinus Extract

82/520

Timothy Pollen Extract

82/585

Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)

82/587

Interferon Gamma (Human, Leukocyte derived)

82/632

Parathyroid Hormone, Bovine

82/652

Human Serum Vitamin B12, Pernicous anaemia

83/500

Insulin, Human

83/501

Beta Thromboglobulin, Purified Human

83/505

Plaet Factor 4 Human, Purified

83/511

Insulin, Bovine

83/514

Interferon alpha-1D, (Human rDNA derived)

83/515

Insulin, Porcine

83/537

Influenza Antigen A/Philippines/2/82

83/545

Influenza anti A/Philippine/2/82 Serum (sheep)

83/550

Influenza Antigen A/Brazil/11/78

83/575

Follicle Stimulating Hormone, Pituitary

84/500

Prolactin, Human

84/514

Proinsulin, Bovine

84/522

Birch Pollen Extract

84/528

Proinsulin, Porcine

84/538

Influenza Antigen A/Chile/1/83

84/542

Influenza Antigen B/Norway/1/84

84/581

Short Ragweed Pollen Extract

84/614

Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin)

84/628

Anti-c Serum, Human

84/636

Influenza anti B/USSR/100/83 Serum(sheep)

84/640

Influenza anti A/Chile/1/8 Serum(sheep)

84/677

Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)

84/685

Dog (Canis Familiaris) Hair Dander Extract

85/506

C-Reactive Protein, Human

85/516

Influenza anti A/Equine/Kentucky/1/81 HA Serum (sheep)

85/520

Influenza Antigen A/Equine/Kentucky/1/81

85/522

Thyroid Stimulating Hormone beta subunit

85/551

Anti-Rye Grass Serum, Human

85/616

Haemoglobin F Lysate, Raised

85/669

Atrial Natriuretic Factor, Human

86/500

Interleukin- 2 (Human, rDNA derived)(2nd International Standard)

86/536

Angiotensin I Human Type Synthetic

86/538

Angiotensin II (2.5µg)

86/552

Interleukin-1 Beta (Human, rDNA derived)

86/576

Influenza Antigen A/Mississippi/1/85

86/590

Influenza anti A/Mississippi/1/85 Serum(sheep)

86/592

Influenza anti B/Ann Arbor/1/86/HA Serum (sheep)

86/630

Influenza Antigen B/Ann Arbor/1/86

86/632

Interleukin-1 alpha (Human rDNA derived)

86/678

Interleukin-1 alpha (Human, rDNA derived)

86/680

Interleukin-1 beta (Human, rDNA derived)

86/690

Inhibin, Porcine

87/510

Influenza Antigen A/Equine/Miami/63

87/578

Influenza anti A/Leningrad/360/86 Serum (sheep)

87/584

Influenza Antigen A/Leningrad/360/86

87/586

Interferon Gamma (Human, rDNA derived)

87/640

Tumour Necrosis Factor beta (Human, rDNA derived)

87/654

Anti-Ferritin Monoclonal Antibody (1)

87/662

Anti-Ferritin Monoclonal Antibody (2)

87/714

Influenza Antigen A/Sichuan/2/87

87/774

Influenza Antigen B/Victoria/2/87

88/522

Bordela pertussis (Whole cell vaccine) 3BRP

88/532

Tumour Necrosis Factor alpha (Mouse, rDNA derived)

88/554

Influenza Antigen B/Beijing/1/87

88/556

Calcitonin, Eel

88/638

Thyroxine-binding globulin

88/646

Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived)

88/654

Influenza Antigen A/England/427/88

88/656

Interleukin-4 (Human, rDNA derived)

88/672

Influenza anti A/Sichuan/2/87 Serum(sheep)

88/678

Influenza anti B/Beijing/1/87 Serum(sheep)

88/846

Influenza anti A/England/427/88 Serum(sheep)

89/512

Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived)

89/514

Transforming Growth Factor beta-1 (Human, rDNA derived)

89/516

Transforming Growth Factor beta-1 (Bovine)

89/518

Transforming Growth Factor beta-2 (Bovine)

89/520

Interleukin-8 (Human, rDNA derived)

89/530

Anti-Bordela pertussis serum (Human)

89/544

Renin, Human, rec DNA

89/548

Interleukin-6 (Human, rDNA derived)

89/568

Influenza Antigen A/OMS/5389/88

89/594

Bordela pertussis (W28) LPS 2ug

89/596

Bordela pertussis anti-agglutinogen 1(rabbit)

89/598

Bordela pertussis anti-agglutinogen 2 (rabbit)

89/600

Bordela pertussis anti-agglutinogen 3 (rabbit)

89/620

Calcitonin, Human

89/666

Haemoglobin A2 Lysate, Raised

89/670

Bordela pertussis (W28) LPS25ug

90/500

Influenza Antigen A/Shanghai/16/89

90/502

Influenza Antigen A/Guizhou/54/89

90/504

Influenza anti A/Guangdong/39/89 Serum(sheep)

90/520

Bordela pertussis, filamentous haemagglutinin (FHA)

90/530

Interleukin-7 (Human, rDNA derived)

90/534

Mumps Vaccine (Live)

90/586

Interleukin-5 (Human, rDNA derived)

90/636

HIV-1 P24 Antigen

90/654

Bordela pertussis 69kD

90/690

Anti-Varicella-Zoster Antibody

90/696

Transforming Growth Factor beta-2, Human, rec DNA

90/712

Basic Fibroblast Growth Factor (Human, rDNA derived)

90/784

Influenza Virus infectious NIB-26 (H3N2)

91/510

Interleukin-3 (Human, rDNA derived)

91/530

Epidermal Growth Factor (Human, rDNA derived)

91/550

Epidermal Growth Factor (1-52) (Human, rDNA derived)

91/554

Insulin-like growth Factor 1

91/562

Anti-D for use with papain preparation 92/658

91/612

Influenza anti A/Taiwan/1/86 Serum (sheep)

91/624

Inhibin A, Human, recombinant

91/626

Activin A, Human, Recombinant

91/656

Interleukin-4 (Mouse, rDNA derived)

91/658

Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)

91/662

Interleukin-3 (Mouse, rDNA derived)

91/670

Influenza Virus infectious NIB-27 (H1N1)

91/678

Interleukin-9 (Human,rDNA derived)

91/682

Stem Cell Factor (Human rDNA derived)

91/688

Rubella Vaccine (Live)

92/510

Follicle Stimulating Hormone, Human, recombinant

92/512

Follicle Stimulating Hormone, urofollitropin Human Urinary

92/518

Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)

92/520

Rantes (Human, rDNA derived)

92/530

Influenza Antigen A/Texas/36/91

92/582

Influenza anti B/Yamagata/16/88 Serum(sheep)

92/628

Influenza Antigen B/Yamagata/16/88

92/632

Influenza anti A/Beijing/352/89 (H3N2) Serum (sheep)

92/644

Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)

92/648

Measles Vaccine (Live)

92/654

Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human

92/658

Papain preparation for use with Anti-D preparation 91/562

92/680

Serum amyloid A protein

92/734

Influenza Virus infectious A/Beijing/32/92 (H3N2)

92/738

Influenza Virus infectious A/Shanghai/24/90

92/788

Interleukin-11 (Human, rDNA derived)

92/794

Monocyte Chemoattractant Protein-1 (Human,rDNA derived)

93/500

Influenza Antigen A/Beijing/32/92

93/516

Influenza Antigen A/Shanghai/24/90

93/518

Influenza anti A/Beijing/32/92 (H3N2) Serum (sheep)

93/522

Influenza anti A/Shanghai/24/90 (H3N2) Serum (sheep)

93/526

Batroxobin

93/556

Nerve Growth Factor (Human, rDNA derived)

93/560

Insulin-like growth Factor Binding Protein-3

93/562

Leukaemia Inhibitory Factor (Human, rDNA derived)

93/564

Oncostatin M (Human, rDNA derived)

93/566

Interleukin-2 (Mouse, rDNA derived)

93/568

Influenza Virus infectious A/Beijing/359/89 (H3N2)

93/572

Influenza Virus infectious A/Guizhou/54/89 (H3N2)

93/574

Bone morphogenetic Protein-2 (Human, rDNA derived)

93/668

Interleukin-1 beta (Mouse, rDNA derived)

93/672

Interleukin-1 alpha (Mouse, rDNA derived)

93/686

Influenza Virus infectious A/Shangdong/9/93 (H3N2)

93/692

Influenza Virus infectious B/Panama/45/90

93/722

Interleukin-10 (Human rDNA derived)

93/730

Interleukin-6 (Mouse, rDNA derived)

93/740

Interleukin-7 (Mouse, rDNA derived)

93/816

Influenza Virus infectious A/Harbin/15/92 (H3N2)

94/500

Influenza Antigen B/Panama/45/90

94/504

Influenza anti A/Shanghai/9/93 Serum(sheep)

94/516

Influenza Antigen A/Shangdong/9/93

94/520

Influenza anti B/Panama/45/90 Serum(sheep)

94/532

Pertussis Vaccine (Whole Cell)

94/572

Ferritin, Human, recombinant

94/622

Interleukin-13 (Human, rDNA derived)

94/674

Thyroid Stimulating Hormone, Human recombinant

94/684

Ciliary Neurotrophic Factor (Human, rDNA derived)

94/718

Staphylokinase, rec (STAR)

94/728

Plaet-derived Growth Factor-BB (Human, rDNA derived)

94/730

Tissue Plasminogen Activator (tPA) Antigen in Plasma

94/754

Interferon Omega (Human, rDNA derived)

94/762

Influenza Virus infectious RESVIR-8 (H3N2)

94/766

Influenza Virus infectious NIB-34 (H3N2)

94/784

Interferon alpha (Human, leukocyte derived)

94/786

Interferon alpha Concensus Sequence (Human rDNA derived)

94/790

MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA * 472-C

95/500

Hepatitis A Vaccine, inactivated

95/510

Influenza Antigen A/Texas/36/91

95/516

Influenza Antigen A/Johannesburg/33/94

95/522

Anti-HBc (Anti-hepatitis B core antigen)

95/524

Influenza anti A/Johannesburg/33/94 Serum(sheep)

95/528

Folate, Whole Blood Haemolysate

95/542

MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C

95/544

Interleukin-12 (Human, rDNA derived)

95/554

Interleukin-15 (Human, rDNA derived)

95/564

Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)

95/566

Interferon alpha-2b (Human, rDNA derived)

95/568

Interferon Alpha n1 (Human lymphoblastoid cell derived)

95/572

Interferon alpha-1/8 (Human, rDNA derived)

95/574

Interferon Alpha n3 (Human, leukocyte derived)

95/580

Interferon alpha-2c (Human, rDNA derived)

95/584

Anti-hepatitis E Serum, Human

95/646

Parathyroid Hormone 1-84, human, recombinant(1st International Standard)

95/650

Interferon alpha-2a (Human, rDNA derived)

95/668

Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)

95/674

Anti-Meningococcal Serogroup A mAb

95/678

Anti-Meningococcal Serogroup C mAb

96/528

Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)

96/532

FMS-like tyrosine kinase 3 ligand (Human, rDNA derived)

96/534

Brain-derived Neurotrophic Factor (Human, rDNA derived)

96/538

Insulin-like growth Factor-II (Human rDNA derived)

96/556

Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived)

96/564

Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived)

96/572

MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C

96/578

MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C

96/602

Luteinizing Hormone, Human, recombinant

96/666

Anti-Human Globulin

96/668

Prostate Specific Antigen (free)

96/784

Inhibin B, Human

96/830

Influenza Virus infectious A/Bayern/7/95

96/836

Influenza Virus infectious RESVIR-9 (H3N2)

96/848

Influenza Virus infectious A/Shenzhen/227/95 (H1N1)

96/850

Influenza Virus infectious NIB-39 (H1N1)

97/518

Influenza Antigen A/Johannesburg/82/96

97/538

Anti-Granulocyte Macrophage Colony Stimulating Factor Serum

97/550

Islet Cell Antibodies

97/558

Bordela pertussis anti 69kD serum (sheep)

97/562

Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)

97/564

Bordela pertussis anti FHA serum (sheep)

97/572

Bordela pertussis PT anti serum (sheep)

97/574

Bordela pertussis anti Fim3 serum (sheep)

97/584

Influenza Antigen A/Equine/Newmarket/2/93

97/594

Leptin, Human, Recombinant

97/596

Influenza Antigen A/Equine/Newmarket/1/93

97/600

Interleukin-2 Soluble Receptor (human, rDNA derived)

97/610

Influenza anti A/equine/Newmarket/1/93 Serum(sheep)

97/612

Influenza anti- A/Nanchang/933/95 (H3N2) HA serum

97/614

Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)

97/626

Leptin, Mouse, Recombinant

97/642

Bordela pertussis anti serum (mouse) 1RR

97/646

Anti-Hepatitis A Immunoglobulin, Human (W1041)

97/648

Anti-Measles serum (3rd International Standard)

97/662

Anti-Streptolylsin-O, Human,

97/692

Influenza Virus infectious IVR-108 (H3N2)

97/714

Prolactin, Human, recombinant

97/722

Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)

97/726

Influenza Virus infectious B/Harbin/7/94

97/748

Influenza Antigen B/Harbin/7/94

97/756

MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G

97/758

MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G

97/760

Influenza Antigen A/Beijing/262/95

98/524

MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, *481-G

98/544

Influenza Virus infectious RESVIR-13 (H3N2)

98/572

Diphtheria and Tetanus Antitoxin, Guinea Pig Serum

98/574

Somatropin

98/580

Prolactin Human, recombinant, glycosylated

98/582

Prolactin, Human, recombinant, non-glycosylated

98/586

Calcitonin, Salmon

98/596

MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G

98/600

Influenza Virus infectious NIB-40 (H5N3)

98/604

Influenza anti B/Harbin/7/94/HA Serum (sheep)

98/610

Influenza Virus infectious ARIV-1 (H5N3)

98/666

Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)

98/686

Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)

98/708

Haemiglobincyanide

98/714

Tissue Plasminogen Activator, Human, Recombinant

98/718

Neurotrophin 3

98/722

Meningococcal group A polysaccharide

98/762

Influenza Virus infectious Resvir-14 (H3N2)

98/772

Influenza anti A/Beijing/262/95 Serum (sheep)

98/774

Influenza Antigen B/Shangdong/7/97

98/778

Influenza Virus infectious A/Sichuan/346/98 (H3N2)

99/506

Anti-PT S1 subunit Monoclonal Antibody (1B7)

99/508

Anti-PT S1 subunit Monoclonal Antibody (1D7)

99/510